News | June 07, 2023
Mixed prospects for Merck lawsuit against US federal government, says GlobalData
The judicial response to industry lawsuits on drug pricing regulations have been mixed in the past
The judicial response to industry lawsuits on drug pricing regulations have been mixed in the past
The new Biolys provides higher concentration of L-lysine
The investment will include facility and equipment improvements and the addition of 60 full-time positions in 3M manufacturing facilities in Europe.
Tremelimumab in combination with Durvalumab is indicated for the treatment of patients with unresectable hepatocellular carcinoma (uHCC)
One thousand times more soluble than L-cystine at neutral pH
The latest extension of Masimo and Philips’ ongoing collaboration will help enable clinicians to make quick and informed decisions without the need for additional monitoring equipment
This fresh infusion of capital will enable ImmunoACT to fast track the additional supply of the lead candidate HCAR-19
Capnopharm’s new CapnoPen is the first PIPAC nebulizer to obtain CE marking under the new MDR regulation 2017/745
Pharmaceutical sales was flat and stood at Rs. 309 crore as compared to Rs. 308 crore in Q4 FY22
The product is expected to be launched in June 2023
Subscribe To Our Newsletter & Stay Updated
